Category: Cerapedics Inc.Syndicate content

GE gets behind Cerapedics and its i-FACTOR bone graft

April 21, 2014 by Arezu Sarvestani

Colorado-based Cerapedics closes $9 million in venture debt financing from GE Capital's Health Financial Services in support of the i-FACTOR Peptide Enhanced Bone Graft.

GE gets behind Cerapedics and its i-FACTOR bone graft

Tech and healthcare giant GE (NYSE:GE) put some skin in Cerapedics and its i-FACTOR bone graft, funding a $9 million venture debt financing round for the Colorado-based company.

ConforMIS lures Zimmer ops director to be its new operations SVP | Personnel Moves

May 16, 2013 by Brad Perriello

Matthew Scott, former director of operations for Zimmer Holdings' dental business, is named senior vice president of operations for custom knee implant maker ConforMIS.

ConforMIS lures Zimmer ops director to be its new COO

ConforMIS lured Zimmer's dental business operations director, Matthew Scott, away to be its new chief operating officer as it looks to scale up its customized knee implant business.

The Bedford, Mass.-based medical device company said Scott bring's a decade's worth of ops experience from his tenure at Zimmer. ConforMIS makes knee replacement implants and instrumentation that are custom-fit to patients' morphology.

Cerapedics raises $19M in Series C round

December 12, 2012 by MassDevice staff

Medical device company Cerapedics raises $19 million in a Series C funding round for its cervical spine bone graft technology.


Cerapedics said it closed a Series C equity round worth $19 million, led by new investors MedImmune Ventures and CVF LLC, an affiliate of Henry Crown & Co.

Existing backers OrbiMed Advisors and NGN Capital also participated, according to a press release.

The Dow flirts with 13,000 | Wall Street Beat

February 22, 2012 by MassDevice staff

The Dow Jones Industrial Average breaks 13,000 for the first time since the Lehman Brothers collapse triggered an economic implosion, before falling back to close just under that high-water mark; also, Teleflex inks PCA pump GPO deal; a Funding Roundup; and analysts' ups and downs. Wall Street Beat

The Dow Jones Industrial Average, a longtime bellwether for the U.S. economy, flirted yesterday with a high-water mark not seen since Lehman Brothers' collapse triggered an economic implosion more than 4 years ago.

The Dow reached 13,005.04 at one point yesterday, before subsiding to close at 12,965.69 yesterday. It's the first time the index has climbed that high since May 2008.

Investors were heartened by a deal struck in the European Union to resolve Greece's debt crisis and by positive earnings results from a pair of American stalwarts.

Covidien completes enrollment on ev3 atherectomy device study | Research roundup

April 11, 2011 by MassDevice staff

Covidien wraps up enrollment for a post-market study on the effectiveness of the SilverHawk peripheral arterial disease treatment system it acquired in its $2.6 billion buyout of ev3 last year.


Covidien plc (NYSE:COV) said it has enough patients to evaluate the effectiveness of an arterial plaque removal system it acquired in its buyout of ev3 Inc. last year.